• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高级别卵巢癌中的能量底物转运蛋白:基因表达与临床意义。

Energy Substrate Transporters in High-Grade Ovarian Cancer: Gene Expression and Clinical Implications.

机构信息

Department of Gynecology and Gynecological Oncology, Medical University of Bialystok, Marii Skłodowskiej-Curie 24A Street, 15-276 Bialystok, Poland.

Department of Physiology, Medical University of Bialystok, Mickiewicza 2C Street, 15-222 Bialystok, Poland.

出版信息

Int J Mol Sci. 2022 Aug 11;23(16):8968. doi: 10.3390/ijms23168968.

DOI:10.3390/ijms23168968
PMID:36012230
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9408757/
Abstract

Ovarian cancer is a non-homogenous malignancy. High-grade serous carcinoma (HGSC) is the most common subtype, and its drug resistance mechanisms remain unclear. Despite the advantages of modern pharmacotherapy, high-grade ovarian cancer is associated with a poor prognosis and research into targeted therapies is in progress. The aim of the study was to assess the dominant energy substrate transport mechanism in ovarian cancer cells and to verify whether genomic aberrations could predict clinical outcomes using the Cancer Genome Atlas (TCGA) dataset. Total RNA was extracted from HGSC frozen tissues, and the expression of selected genes was compared to respective controls. , , and genes were significantly overexpressed in carcinomas compared with controls, while expression of , , , , and was decreased. No differences were found in , , and . The transcript content of mitochondrial genes such as , and was similar between groups, while the level declined in ovarian cancer. Additionally, the level was reduced and was elevated in cancer tissue from patients with 'small' primary tumor and omental invasion accompanied by ascites as compared to patients that exhibited greater tendencies to metastasize to lymph nodes with clear omentum. Based on TCGA, higher and and lower expression indicated poorer overall survival in patients with ovarian cancer. In conclusion, the presented data show that there is no exclusive energy substrate in HGSC. However, this study indicates the advantage of glucose and lactate transport over fatty acids, thereby suggesting potential therapeutic intervention targets to impede ovarian cancer growth.

摘要

卵巢癌是一种非同质恶性肿瘤。高级别浆液性癌(HGSC)是最常见的亚型,其耐药机制尚不清楚。尽管现代药物治疗有优势,但高级别卵巢癌预后不良,目前正在进行靶向治疗的研究。本研究旨在评估卵巢癌细胞中主要能量底物转运机制,并使用癌症基因组图谱(TCGA)数据集验证基因组异常是否可以预测临床结果。从 HGSC 冷冻组织中提取总 RNA,并将选定基因的表达与各自的对照进行比较。与对照组相比, 、 、 和 基因在癌组织中显著过表达,而 、 、 、 和 的表达降低。 、 、 和 之间没有差异。线粒体基因如 、 和 的转录物含量在各组之间相似,而卵巢癌中的 水平下降。此外,与表现出更大淋巴结转移倾向且大网膜清晰的患者相比,在原发性肿瘤较小且伴有腹水的网膜侵犯患者的癌组织中, 水平降低, 水平升高。基于 TCGA,卵巢癌患者中 和 表达较高且 表达较低,总生存期较差。总之,所提供的数据表明 HGSC 中没有独特的能量底物。然而,本研究表明葡萄糖和乳酸转运的优势超过脂肪酸,从而为阻碍卵巢癌生长提供了潜在的治疗干预靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b2/9408757/4919e23b2bcd/ijms-23-08968-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b2/9408757/26b8a5b69961/ijms-23-08968-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b2/9408757/5304166b6f1a/ijms-23-08968-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b2/9408757/0beca04993c6/ijms-23-08968-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b2/9408757/5d4e5b16f9b7/ijms-23-08968-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b2/9408757/9dc844e5e216/ijms-23-08968-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b2/9408757/f4eebd49f8a6/ijms-23-08968-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b2/9408757/4919e23b2bcd/ijms-23-08968-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b2/9408757/26b8a5b69961/ijms-23-08968-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b2/9408757/5304166b6f1a/ijms-23-08968-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b2/9408757/0beca04993c6/ijms-23-08968-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b2/9408757/5d4e5b16f9b7/ijms-23-08968-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b2/9408757/9dc844e5e216/ijms-23-08968-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b2/9408757/f4eebd49f8a6/ijms-23-08968-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80b2/9408757/4919e23b2bcd/ijms-23-08968-g007.jpg

相似文献

1
Energy Substrate Transporters in High-Grade Ovarian Cancer: Gene Expression and Clinical Implications.高级别卵巢癌中的能量底物转运蛋白:基因表达与临床意义。
Int J Mol Sci. 2022 Aug 11;23(16):8968. doi: 10.3390/ijms23168968.
2
Greater transport efficiencies of the membrane fatty acid transporters FAT/CD36 and FATP4 compared with FABPpm and FATP1 and differential effects on fatty acid esterification and oxidation in rat skeletal muscle.与FABPpm和FATP1相比,膜脂肪酸转运蛋白FAT/CD36和FATP4具有更高的转运效率,且对大鼠骨骼肌中脂肪酸酯化和氧化有不同影响。
J Biol Chem. 2009 Jun 12;284(24):16522-16530. doi: 10.1074/jbc.M109.004788. Epub 2009 Apr 20.
3
[Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].[PAX8、PAX2、p53和RAS在卵巢及输卵管中的表达及其对卵巢高级别浆液性癌起源的意义]
Zhonghua Fu Chan Ke Za Zhi. 2017 Oct 25;52(10):687-696. doi: 10.3760/cma.j.issn.0529-567X.2017.10.008.
4
Nicotinamide N-methyltransferase overexpression may be associated with poor prognosis in ovarian cancer.烟酰胺 N-甲基转移酶过表达可能与卵巢癌预后不良相关。
J Obstet Gynaecol. 2021 Feb;41(2):248-253. doi: 10.1080/01443615.2020.1732891. Epub 2020 Apr 14.
5
Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression.CD147/EMMPRIN 与单羧酸转运蛋白和多药耐药蛋白的共表达与上皮性卵巢癌的进展相关。
Clin Exp Metastasis. 2010 Dec;27(8):557-69. doi: 10.1007/s10585-010-9345-9. Epub 2010 Jul 24.
6
Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.乳酸/氢离子协同转运蛋白MCT1和MCT4及其伴侣蛋白CD147的表达可预测透明细胞肾细胞癌的肿瘤进展:免疫组化和癌症基因组图谱数据分析
Hum Pathol. 2015 Jan;46(1):104-12. doi: 10.1016/j.humpath.2014.09.013. Epub 2014 Oct 7.
7
Tomm34 is commonly expressed in epithelial ovarian cancer and associates with tumour type and high FIGO stage.Tomm34 在卵巢上皮性癌中普遍表达,与肿瘤类型和 FIGO 高分期相关。
J Ovarian Res. 2019 Mar 27;12(1):30. doi: 10.1186/s13048-019-0498-0.
8
Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer.ASCT2 与 p-mTOR 在卵巢上皮性癌发病机制及预后中的临床相关性。
Oncol Rep. 2018 Dec;40(6):3725-3733. doi: 10.3892/or.2018.6729. Epub 2018 Sep 24.
9
Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma.神经降压素在高级别浆液性卵巢癌中表达增加,伴有浆液性输卵管上皮内癌的证据。
J Pathol. 2019 Jul;248(3):352-362. doi: 10.1002/path.5264. Epub 2019 May 14.
10
Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.TP53的分子改变是卵巢高级别浆液性癌的一个决定性特征:对癌症基因组图谱卵巢研究中缺乏TP53突变病例的重新审视。
Int J Gynecol Pathol. 2016 Jan;35(1):48-55. doi: 10.1097/PGP.0000000000000207.

引用本文的文献

1
High CD36 expression in the tumor microenvironmental vasculature correlates with unfavorable overall survival in high grade serous ovarian cancer.肿瘤微环境脉管系统中高表达的CD36与高级别浆液性卵巢癌患者不良的总生存期相关。
Sci Rep. 2025 Jun 3;15(1):19354. doi: 10.1038/s41598-025-01917-z.
2
From COPD to cancer: indacaterol's unexpected role in combating NSCLC.从慢性阻塞性肺疾病到癌症:茚达特罗在对抗非小细胞肺癌中意想不到的作用。
Front Pharmacol. 2025 Apr 3;16:1579126. doi: 10.3389/fphar.2025.1579126. eCollection 2025.
3
Transcription factor A, mitochondrial promotes lymph node metastasis and lymphangiogenesis in epithelial ovarian carcinoma.

本文引用的文献

1
Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study.全球卵巢癌负担、风险因素及时间趋势:一项全球研究。
Cancers (Basel). 2022 Apr 29;14(9):2230. doi: 10.3390/cancers14092230.
2
Role of Amino Acid Transporter SNAT1/SLC38A1 in Human Melanoma.氨基酸转运体SNAT1/SLC38A1在人类黑色素瘤中的作用
Cancers (Basel). 2022 Apr 26;14(9):2151. doi: 10.3390/cancers14092151.
3
Fatty Acid Metabolism in Ovarian Cancer: Therapeutic Implications.脂肪酸代谢与卵巢癌:治疗学意义。
线粒体转录因子A促进上皮性卵巢癌的淋巴结转移和淋巴管生成。
Open Med (Wars). 2025 Feb 7;20(1):20241089. doi: 10.1515/med-2024-1089. eCollection 2025.
4
Role of solute carrier transporters in ovarian cancer (Review).溶质载体转运蛋白在卵巢癌中的作用(综述)。
Int J Mol Med. 2025 Feb;55(2). doi: 10.3892/ijmm.2024.5465. Epub 2024 Nov 29.
5
Alteration of glucose metabolism and expression of glucose transporters in ovarian cancer.卵巢癌中葡萄糖代谢及葡萄糖转运蛋白表达的改变
Explor Target Antitumor Ther. 2024;5(2):384-399. doi: 10.37349/etat.2024.00224. Epub 2024 Apr 24.
6
Comprehensive analysis of T cell exhaustion related signature for predicting prognosis and immunotherapy response in HNSCC.用于预测头颈部鳞状细胞癌预后和免疫治疗反应的T细胞耗竭相关特征的综合分析
Discov Oncol. 2024 Mar 2;15(1):56. doi: 10.1007/s12672-024-00921-5.
7
ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2/STAT3 pathway and interacting with ESM1.ANGPTL4 通过激活 JAK2/STAT3 通路并与 ESM1 相互作用,加速卵巢浆液性囊腺癌肿瘤微环境中的肿瘤发生和血管生成。
J Transl Med. 2024 Jan 11;22(1):46. doi: 10.1186/s12967-023-04819-8.
8
CircRNA-regulated glucose metabolism in ovarian cancer: an emerging landscape for therapeutic intervention.环状 RNA 调控卵巢癌中的葡萄糖代谢:治疗干预的新领域。
Clin Transl Oncol. 2024 Mar;26(3):584-596. doi: 10.1007/s12094-023-03285-4. Epub 2023 Aug 14.
9
Establishment of a prognostic model for ovarian cancer based on mitochondrial metabolism-related genes.基于线粒体代谢相关基因建立卵巢癌预后模型。
Front Oncol. 2023 May 15;13:1144430. doi: 10.3389/fonc.2023.1144430. eCollection 2023.
10
TRIM3 inhibits colorectal cancer cell migration and lipid droplet formation by promoting FABP4 degradation.TRIM3通过促进FABP4降解来抑制结肠癌细胞迁移和脂滴形成。
Histol Histopathol. 2024 Feb;39(2):239-250. doi: 10.14670/HH-18-627. Epub 2023 May 11.
Int J Mol Sci. 2022 Feb 16;23(4):2170. doi: 10.3390/ijms23042170.
4
Characterizing Endocrine Status, Tumor Hypoxia and Immunogenicity for Therapy Success in Epithelial Ovarian Cancer.描述上皮性卵巢癌的内分泌状态、肿瘤缺氧和免疫原性,以预测治疗效果。
Front Endocrinol (Lausanne). 2021 Nov 17;12:772349. doi: 10.3389/fendo.2021.772349. eCollection 2021.
5
FABP4 is an independent risk factor for lymph node metastasis and poor prognosis in patients with cervical cancer.脂肪酸结合蛋白4(FABP4)是宫颈癌患者发生淋巴结转移和预后不良的独立危险因素。
Cancer Cell Int. 2021 Oct 26;21(1):568. doi: 10.1186/s12935-021-02273-4.
6
Branched chain amino acids-friend or foe in the control of energy substrate turnover and insulin sensitivity?支链氨基酸——在能量底物周转和胰岛素敏感性控制中是友还是敌?
Crit Rev Food Sci Nutr. 2023;63(15):2559-2597. doi: 10.1080/10408398.2021.1977910. Epub 2021 Sep 20.
7
Integrative Analysis Identified MCT4 as an Independent Prognostic Factor for Bladder Cancer.综合分析确定MCT4为膀胱癌的独立预后因素。
Front Oncol. 2021 Aug 26;11:704857. doi: 10.3389/fonc.2021.704857. eCollection 2021.
8
Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation.专为医学研究量身定制的基于网络的生存分析工具(KMplot):开发与应用
J Med Internet Res. 2021 Jul 26;23(7):e27633. doi: 10.2196/27633.
9
MCT4 Promotes Tumor Malignancy in F98 Glioma Cells.MCT4促进F98胶质瘤细胞的肿瘤恶性程度。
J Oncol. 2021 Apr 14;2021:6655529. doi: 10.1155/2021/6655529. eCollection 2021.
10
PGC1α Promotes Cisplatin Resistance in Ovarian Cancer by Regulating the HSP70/HK2/VDAC1 Signaling Pathway.PGC1α 通过调控 HSP70/HK2/VDAC1 信号通路促进卵巢癌顺铂耐药。
Int J Mol Sci. 2021 Mar 3;22(5):2537. doi: 10.3390/ijms22052537.